Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Down 66.1% in December

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSFGet Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 19,500 shares, a decrease of 66.1% from the December 15th total of 57,500 shares. Based on an average daily volume of 500 shares, the short-interest ratio is currently 39.0 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

OTCMKTS SFOSF remained flat at $1.70 during trading hours on Monday. The stock’s fifty day moving average is $1.85 and its 200 day moving average is $1.74. Shanghai Fosun Pharmaceutical has a 12-month low of $1.50 and a 12-month high of $2.24.

About Shanghai Fosun Pharmaceutical (Group)

(Get Free Report)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments.

Further Reading

Receive News & Ratings for Shanghai Fosun Pharmaceutical (Group) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Fosun Pharmaceutical (Group) and related companies with MarketBeat.com's FREE daily email newsletter.